Recent Press Releases

Cytokinetics Provides Development Program Update for Tirasemtiv

Robust Effects of Tirasemtiv on Slow Vital Capacity Observed in BENEFIT-ALS Support Progression to Phase III Company Believes Effects on Slow Vital Capacity Could Support Registration Path For...

CUBIST PHARMACEUTICALS NAMES ROBERT J. PEREZ CHIEF EXECUTIVE OFFICER

— 10/20/2014 Michael W. Bonney to Become Non-Executive Chair of the Board of Directors Kenneth M. Bate to Become Lead Independent Director Lexington, Mass., October 20, 2014 – Cubist...

Interim Chief Financial Officer James Bowling to Step Down

Interim Chief Financial Officer James Bowling to Step Down DUBLIN, October 20, 2014 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) announces that James Bowling, Interim Chief Financial Officer...

Phase II Data in Crohn's Disease for Celgene's Oral Antisense Therapy GED-0301 to Be Presented at UEG Week 2014

BOUDRY, Switzerland--(BUSINESS WIRE)-- Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ:CELG), today announced that results from a double-blind,...

TesoRx and Aspen Group Conclude Investment and Licensing Agreement

(Menlo Park, CA, United States and Grande Bay, Mauritius) October 20, 2014 – TesoRx Pharma, LLC (http://www.tesorx.com), a specialty pharmaceutical company, announced today that it has licensed...

SELLAS Life Sciences Group Selects PPD As Its Strategic CRO Partner To Advance Zolpidem And WT1 Cancer Vaccine

ZUG, Switzerland and NEW YORK -- SELLAS Life Sciences Group (SELLAS), a Swiss-based development-stage biopharmaceutical company, today announced that it has signed a definitive master service...

PureTech Announces Expansion with Oversubscribed $55M Funding Round

BOSTON, Oct. 20, 2014 -- PureTech, a science and technology development and commercialization company tackling big healthcare problems, announced today the closing of a $55 million growth stage...

NewLink Genetics Announces Exclusive Worldwide Licensing Agreement for Development of NLG919, an IDO Inhibitor in Phase 1, and Research Collaboration for the Discovery of Next Generation IDO/TDO Inhibitors

AMES, IA -- (Marketwired) -- 10/20/14 -- NewLink Genetics Corporation (NASDAQ: NLNK), a biopharmaceutical company focused on discovering, developing, and commercializing novel immunotherapeutics to...

Cardiorentis AG and Roche Announce Collaboration to Establish Therapeutic Impact of Ularitide

ZUG and ROTKREUZ, Switzerland -- Cardiorentis AG, a privately held biopharmaceutical company, today announced a collaboration with Roche to establish the therapeutic efficacy and safety of Ularitide,...

Pharmacyclics Enters Into Agreement with Roche to Evaluate IMBRUVICA® and GAZYVA® in Lymphoma and Leukemia

SUNNYVALE, Calif. -- Pharmacyclics, Inc. (PCYC) today announced that it has entered into a master clinical drug supply agreement with Roche (SIX: RO, ROG; OTCQX: RHHBY) to evaluate the safety,...

Regeneron Genetics Center Fully Operational, Announces New Collaborations and Key Appointments

TARRYTOWN, N.Y. -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the Regeneron Genetics Center LLC (RGC), a wholly-owned subsidiary, has formed important new collaborations with...

Amgen Files Lawsuit Against Sanofi And Regeneron For Patent Infringement

Amgen Seeks Injunction Related to PCSK9 Inhibitor THOUSAND OAKS, Calif., Oct. 17, 2014 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that it filed a lawsuit in the United States (U.S.)...

Dr. Lorne Holland Joins DaVita Inc. (DVA) Labs As Chief Lab Officer

DELAND, Fla., Oct. 13, 2014 /PRNewswire/ -- DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, today announced that DaVita...

Pharmatech Associates Appoints Warren G. Baker As Chief Executive Officer

HAYWARD, Calif.--(BUSINESS WIRE)--Pharmatech Associates today announced the appointment of Warren G. Baker as chief executive officer. Baker, a 25-year medical device and healthcare technology...

Pharmatech Hires Richard Aleman to Lead Regulatory Compliance

HAYWARD, Calif.--(BUSINESS WIRE)--Pharmatech Associates today announced the appointment of international regulatory expert Richard Aleman as vice president of Regulatory Compliance. Aleman, a 28-year...

Pharmalink AB Elects Bengt Julander As Chairman

STOCKHOLM, October 14, 2014 /PRNewswire/ -- Pharmalink AB, a specialty pharma company focused on orphan and niche products, has elected Bengt Julander as Chairman of the Board of Directors. He...

Catalent Appoints Senior Vice President and General Counsel

SOMERSET, N.J.--(BUSINESS WIRE)--Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products,...

PuriCore's CEO To Retire

Planned Directorate Changes Michael Ashton to retire as CEO Marella Thorell appointed COO in addition to remaining CFO 14 October 2014 – PuriCore plc (LSE: PURI), a global company focused on...

Stora Enso Has Appointed Johanna Hagelberg As Executive Vice President Sourcing As Of 1 November 2014. This Is A New Role In Stora Enso's Group Leadership Team

Stora Enso has appointed Johanna Hagelberg as Executive Vice President Sourcing as of 1 November 2014. This is a new role in Stora Enso's Group Leadership Team . Johanna Hagelberg joined Stora...